{"id":"W2761878534","doi":"10.1056/nejmoa1614598","title":"Obinutuzumab for the First-Line Treatment of Follicular Lymphoma","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":788,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre","funders":"Cancer Research UK","keywords":"Obinutuzumab; Rituximab; Medicine; Follicular lymphoma; Internal medicine; Oncology; Chemotherapy; Hazard ratio; Adverse effect; Lymphoma; CD20; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006090666,0.0003151784,0.0005726336,0.000279945,0.0002166506,0.0003450796,0.0003915006,0.0003479205,0.002116597],"category_scores_gemma":[0.001065273,0.00008361779,0.0003600077,0.0002239233,0.0002035589,0.0001525071,0.0001827133,0.0006776549,0.0003185412],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008415455,"about_ca_system_score_gemma":0.0006208012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004753201,"about_ca_topic_score_gemma":0.001002526,"domain_scores_codex":[0.999793,0.00008784846,0.000014254,0.00002410479,0.00003595004,0.00004473487],"domain_scores_gemma":[0.9995822,0.0001109983,0.0001407656,0.00002359773,0.00002592762,0.0001165068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.06162788,0.002964958,0.03739648,0.002149317,0.001107627,0.001297074,0.0002697688,0.002632612,0.02375768,0.0006167577,0.007083848,0.8590959],"study_design_scores_gemma":[0.1573042,0.199244,0.3427106,0.002294945,0.005447698,0.0295839,0.0003320476,0.009590229,0.07290135,0.003927694,0.176509,0.0001542525],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9244665,0.06950491,0.001117073,0.001012848,0.0002219772,0.0003602637,0.000178166,0.0001097755,0.00302856],"genre_scores_gemma":[0.9892468,0.008202758,0.0009472892,0.00034494,0.0001630998,0.0001577786,0.0002309664,0.000008756831,0.0006976158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002116597,"threshold_uncertainty_score":0.007080674,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04278529139120291,"score_gpt":0.3180883775896582,"score_spread":0.2753030861984553,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}